- Home
- LEE vs VRCA Comparison
LEE vs VRCA Comparison
Compare LEE & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEE
- VRCA
- Stock Information
- Founded
- LEE 1890
- VRCA 2013
- Country
- LEE United States
- VRCA United States
- Employees
- LEE N/A
- VRCA N/A
- Industry
- LEE Newspapers/Magazines
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- LEE Consumer Discretionary
- VRCA Health Care
- Exchange
- LEE Nasdaq
- VRCA Nasdaq
- Market Cap
- LEE 52.7M
- VRCA 43.0M
- IPO Year
- LEE N/A
- VRCA 2018
- Fundamental
- Price
- LEE $7.46
- VRCA $0.44
- Analyst Decision
- LEE
- VRCA Hold
- Analyst Count
- LEE 0
- VRCA 5
- Target Price
- LEE N/A
- VRCA $6.00
- AVG Volume (30 Days)
- LEE 15.8K
- VRCA 237.2K
- Earning Date
- LEE 05-08-2025
- VRCA 05-13-2025
- Dividend Yield
- LEE N/A
- VRCA N/A
- EPS Growth
- LEE N/A
- VRCA N/A
- EPS
- LEE N/A
- VRCA N/A
- Revenue
- LEE $591,094,000.00
- VRCA $7,566,000.00
- Revenue This Year
- LEE N/A
- VRCA $127.58
- Revenue Next Year
- LEE N/A
- VRCA $88.06
- P/E Ratio
- LEE N/A
- VRCA N/A
- Revenue Growth
- LEE N/A
- VRCA 47.66
- 52 Week Low
- LEE $7.57
- VRCA $0.38
- 52 Week High
- LEE $19.63
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- LEE 33.20
- VRCA 44.12
- Support Level
- LEE $7.35
- VRCA $0.39
- Resistance Level
- LEE $8.80
- VRCA $0.48
- Average True Range (ATR)
- LEE 0.45
- VRCA 0.05
- MACD
- LEE -0.05
- VRCA -0.00
- Stochastic Oscillator
- LEE 5.80
- VRCA 44.95
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.